Answer
In Symkevi, tezacaftor binds CFTR’s MSD-1 and improves processing and trafficking to increase cell-surface CFTR, while ivacaftor increases opening of CFTR channels already at the cell surface, enhancing chloride transport in vitro; the exact mechanisms for F508del-CFTR are unknown.
Sources for this answer
- Symkevi 100 mg/150 mg tablets PLGB 22352/0003Vertex Pharmaceuticals (Europe) Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 14Document updated
Sources checked